Skip to main content
PMC home page
Heart logoLink to Heart
. 1996 Aug;76(2):107–108. doi: 10.1136/hrt.76.2.107

The St Vincent Task Force for diabetes: report of the cardiovascular disease subgroup.

B Pentecost 1, J S Yudkin 1
PMCID: PMC484455  PMID: 8795470

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Accola K. D., Jones E. L., Craver J. M., Weintraub W. S., Guyton R. A. Bilateral mammary artery grafting: avoidance of complications with extended use. Ann Thorac Surg. 1993 Oct;56(4):872–879. doi: 10.1016/0003-4975(93)90347-k. [DOI] [PubMed] [Google Scholar]
  2. Alderman E. L., Corley S. D., Fisher L. D., Chaitman B. R., Faxon D. P., Foster E. D., Killip T., Sosa J. A., Bourassa M. G. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol. 1993 Oct;22(4):1141–1154. doi: 10.1016/0735-1097(93)90429-5. [DOI] [PubMed] [Google Scholar]
  3. Bhan A., Das B., Wasir H. S., Kaul U., Venugopal P. Profile of coronary arterial disease in diabetic patients undergoing coronary arterial bypass grafting. Int J Cardiol. 1991 May;31(2):155–159. doi: 10.1016/0167-5273(91)90210-g. [DOI] [PubMed] [Google Scholar]
  4. Carrozza J. P., Jr, Kuntz R. E., Fishman R. F., Baim D. S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993 Mar 1;118(5):344–349. doi: 10.7326/0003-4819-118-5-199303010-00004. [DOI] [PubMed] [Google Scholar]
  5. Ferguson J. J. NHLI BARI clinical alert on diabetics treated with angioplasty. Circulation. 1995 Dec 15;92(12):3371–3371. doi: 10.1161/01.cir.92.12.3371. [DOI] [PubMed] [Google Scholar]
  6. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980 Jun 28;1(8183):1373–1376. doi: 10.1016/s0140-6736(80)92651-3. [DOI] [PubMed] [Google Scholar]
  7. Hearn J. A., King S. B., 3rd, Douglas J. S., Jr, Carlin S. F., Lembo N. J., Ghazzal Z. M. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design. Circulation. 1993 Nov;88(5 Pt 1):2086–2096. doi: 10.1161/01.cir.88.5.2086. [DOI] [PubMed] [Google Scholar]
  8. Kanojia A., Kasliwal R., Seth A., Bhandari S., Kler T. S., Bhatia M. L. Clinical and coronary arteriographic features and outcome of recent onset unstable angina. Int J Cardiol. 1993 Jun;39(3):173–180. doi: 10.1016/0167-5273(93)90035-f. [DOI] [PubMed] [Google Scholar]
  9. Lawrie G. M., Morris G. C., Jr, Glaeser D. H. Influence of diabetes mellitus on the results of coronary bypass surgery. Follow-up of 212 diabetic patients ten to 15 years after surgery. JAMA. 1986 Dec 5;256(21):2967–2971. [PubMed] [Google Scholar]
  10. Malmberg K., Herlitz J., Hjalmarson A., Rydén L. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. Eur Heart J. 1989 May;10(5):423–428. doi: 10.1093/oxfordjournals.eurheartj.a059505. [DOI] [PubMed] [Google Scholar]
  11. Rensing B. J., Hermans W. R., Vos J., Tijssen J. G., Rutch W., Danchin N., Heyndrickx G. R., Mast E. G., Wijns W., Serruys P. W. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group. Circulation. 1993 Sep;88(3):975–985. doi: 10.1161/01.cir.88.3.975. [DOI] [PubMed] [Google Scholar]
  12. Rosengren A., Welin L., Tsipogianni A., Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ. 1989 Nov 4;299(6708):1127–1131. doi: 10.1136/bmj.299.6708.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  14. Smith S. C., Jr AHA president's letter. Circulation. 1995 Jul 1;92(1):1–1. [PubMed] [Google Scholar]
  15. Ward H., Yudkin J. S. Thrombolysis in patients with diabetes. BMJ. 1995 Jan 7;310(6971):3–4. doi: 10.1136/bmj.310.6971.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yudkin J. S. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ. 1993 May 15;306(6888):1313–1318. doi: 10.1136/bmj.306.6888.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES